Invention Grant
![Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK](/docs/US/2021-07-20/US11066363B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK
-
Application No.: US16668484Application Date: 2019-10-30
-
Publication No.: US11066363B2Publication Date: 2021-07-20
- Inventor: John Hatcher , Nathanael S. Gray , Hwangeun Choi , Pasi Janne , Tinghu Zhang
- Applicant: Dana-Farber Cancer Institute, Inc.
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Burns & Levinson, LLP
- Agent Daniel W. Clarke
- Main IPC: A61K31/403
- IPC: A61K31/403 ; C07D209/80 ; C07D401/14 ; C07D405/14 ; C07D401/04 ; C07D403/04 ; C07D405/04 ; C07D409/04 ; C07D413/04 ; A61P35/00 ; C12N9/12 ; C12N9/96
![Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK](/abs-image/US/2021/07/20/US11066363B2/abs.jpg.150x150.jpg)
Abstract:
The application relates to a compound of Formula (I): which modulates the activity of ALK or SRPK, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which ALK or SRPK plays a role.
Public/Granted literature
- US20200223798A1 6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE INHIBITORS OF ALK AND SRPK AND METHODS OF USE Public/Granted day:2020-07-16
Information query
